Tentative Date for FDA Advisory Panel Review of Cartiva SCI

FDA has tentatively scheduled a meeting of the Orthopaedic and Rehabilitation Devices Panel on April 20, 2016 to review Cartiva's Premarket Approval Application (PMA) for the Cartiva Synthetic Cartilage Implant (SCI), for the treatment of great toe osteoarthritis.

FDA recently completed a 5-day inspection of Cartiva's manufacturing operations...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0